Introduction to Biotechnology ?

Biotechnology is a broad and interdisciplinary field that combines biological sciences with technology to develop products and processes for various applications. It involves the use of living organisms, cells, or biological systems to create or modify products, improve processes, or develop new technologies. Biotechnology is employed in several industries, including medicine, agriculture, environmental management, and food production.

Key Areas of Biotechnology:

1. Medical Biotechnology:
   • Focuses on the development of pharmaceutical drugs, gene therapy, diagnostics, vaccines, and personalized medicine.
   • Includes techniques like recombinant DNA technology and monoclonal antibody production.
2. Agricultural Biotechnology:
   • Involves the use of genetic engineering, plant breeding, and molecular biology to improve crop yield, disease resistance, and pest resistance.
   • Development of genetically modified (GM) crops and livestock.
3. Industrial Biotechnology:
   • Also known as “white biotechnology,” this area focuses on using microorganisms and enzymes for industrial processes, such as biofuels, biodegradable plastics, and food additives.
4. Environmental Biotechnology:
   • Applies biological processes to solve environmental issues like pollution, waste management, and bioremediation.
   • Utilizes microorganisms to break down hazardous materials or pollutants.
5. Food Biotechnology:
   • Encompasses the use of biotechnology in food production, such as the development of functional foods, probiotics, and genetically modified organisms (GMOs) for food security.

Biotechnology Techniques:

• Genetic Engineering: Involves altering the genetic makeup of an organism to achieve desired traits.
• Cloning: Creating genetically identical organisms for research or production purposes.
• PCR (Polymerase Chain Reaction): A technique used to amplify specific DNA sequences.
• CRISPR-Cas9: A gene-editing tool that allows for precise modifications in DNA.

Applications of Biotechnology:

• Healthcare: Creation of new drugs, gene therapies, and medical treatments.
• Agriculture: Development of pest-resistant and high-yield crops, as well as livestock improvements.
• Environmental Conservation: Use of bioremediation to clean up oil spills or toxic waste.
• Food Production: Production of food additives, enzymes, and genetically modified foods.

Ethical Considerations:

Biotechnology raises several ethical issues, especially concerning genetic modification, cloning, and the use of biotechnology in medicine and agriculture. Concerns related to environmental impact, health risks, and the potential for bioterrorism are topics of ongoing debate.

In conclusion, biotechnology plays a crucial role in advancing scientific knowledge and addressing challenges in health, agriculture, and the environment, while presenting new ethical, regulatory, and safety concerns.

What is introduction to Biotechnology ?

Introduction to Biotechnology:

Biotechnology is an interdisciplinary field that combines biological sciences with technology to develop solutions for various industries. It involves the use of living organisms, cells, or biological systems to create new products or processes, improve existing ones, and solve problems in areas such as medicine, agriculture, food production, and environmental management.

The foundation of biotechnology lies in understanding biological processes at the molecular and cellular levels, which allows scientists and engineers to manipulate these processes for beneficial purposes. Through techniques such as genetic engineering, fermentation, and molecular cloning, biotechnology can create valuable products, including medicines, vaccines, and genetically modified crops.

Key Features of Biotechnology:

1. Interdisciplinary Nature: It integrates knowledge from biology, chemistry, physics, engineering, and computer science.
2. Use of Living Organisms: It harnesses the properties of living cells and microorganisms to develop applications for diverse sectors.
3. Technological Advancements: The development and application of advanced technologies, such as gene editing (e.g., CRISPR) and bioprocessing, are core to the field.

Major Areas of Biotechnology:

1. Medical Biotechnology: Focuses on developing new medicines, vaccines, diagnostic tools, and gene therapies for various diseases.
2. Agricultural Biotechnology: Involves improving crop yield, resistance to pests and diseases, and nutritional content through genetic engineering and plant breeding.
3. Industrial Biotechnology: Also called “white biotechnology,” it applies biological processes to produce biofuels, biodegradable plastics, enzymes, and other industrial products.
4. Environmental Biotechnology: Utilizes microorganisms and biological systems to treat waste, clean up pollution, and promote sustainability in environmental management.
5. Food Biotechnology: Focuses on the production of genetically modified foods, food additives, and improved food safety techniques.

Biotechnology is revolutionizing industries, enhancing food security, advancing medical treatments, and contributing to environmental conservation. However, the rapid progress of biotechnology also raises important ethical and safety concerns, particularly in areas like genetic modification, cloning, and bioengineering.

Who is required introduction to Biotechnology ?

An Introduction to Biotechnology is relevant and beneficial for a wide range of individuals, including:

1. Students:

• High School and College Students: Those pursuing courses in biology, life sciences, or related fields can benefit from understanding the basics of biotechnology. This foundational knowledge prepares them for more advanced studies in biotechnology, molecular biology, and genetic engineering.
• Undergraduate and Graduate Students: Students pursuing degrees in fields like biotechnology, bioengineering, molecular biology, biomedical sciences, and agricultural sciences will require a solid introduction to the principles of biotechnology.

2. Professionals:

• Scientists and Researchers: Those working in fields like genetics, microbiology, pharmacology, and agricultural sciences can enhance their research and development efforts by understanding biotechnological techniques and innovations.
• Healthcare Professionals: Doctors, nurses, and medical technicians can gain insights into how biotechnology is shaping medical treatments, diagnostics, and personalized medicine.
• Agricultural Engineers and Agronomists: Understanding biotechnology is essential for those working with genetically modified crops, pest-resistant plants, and sustainable agricultural practices.

3. Entrepreneurs and Business Leaders:

• Biotech Entrepreneurs: Individuals interested in starting or managing companies in the biotechnology industry must understand the basics of biotechnology to make informed decisions about product development, market trends, and innovation.
• Pharmaceutical and Agricultural Industry Executives: Professionals in these industries need knowledge of biotechnology to drive advancements in drug development, crop modification, and sustainable food production.

4. Policy Makers and Regulators:

• Government Officials: Policy makers, lawmakers, and regulatory bodies need an understanding of biotechnology to establish guidelines, regulations, and laws regarding genetic engineering, biosecurity, and environmental impact.
• Ethics Committees: Those involved in overseeing ethical standards related to biotechnology innovations, such as gene editing or GMOs, require knowledge of biotechnology to assess risks and benefits.

5. Consumers and General Public:

• Informed Consumers: With biotechnology impacting food products (e.g., GMOs), medicine (e.g., vaccines, gene therapies), and the environment (e.g., waste treatment), consumers can make informed choices if they understand the basics of biotechnology.
• Environmental Activists: Individuals focused on sustainability and conservation can benefit from understanding how biotechnology is being used for environmental management and pollution control.

6. Educators and Trainers:

• Teachers and Trainers: Those involved in teaching biology, life sciences, or biotechnology-related subjects need a solid grasp of the field to effectively educate students at various academic levels.

In summary, anyone involved in or interested in the fields of science, healthcare, agriculture, business, or environmental sustainability can benefit from an introduction to biotechnology. This knowledge helps individuals make informed decisions, foster innovation, and address the ethical, regulatory, and societal implications of biotechnological advancements.

When is required Introduction to Biotechnology ?

An Introduction to Biotechnology is required at various stages depending on an individual’s goals, career path, and area of interest. Here are some key times when an introduction to biotechnology is needed:

1. At the Start of Academic Pursuits:

• High School or Secondary School: Students interested in science and technology can benefit from an introductory course or exposure to biotechnology concepts during high school. This foundation helps them decide if they want to pursue more advanced studies in life sciences, engineering, or healthcare.
• Undergraduate Studies: Those starting a degree in biotechnology, bioengineering, genetics, agriculture, medicine, or environmental sciences will require a solid understanding of the basics of biotechnology to build upon in more specialized courses.
• Postgraduate Studies: Students entering advanced degrees (Master’s or PhD) in fields such as molecular biology, biomedical sciences, and genetic engineering need foundational knowledge to excel in their research and coursework.

2. Early in a Professional Career:

• Research and Development: Individuals beginning careers in biotechnology-related industries, such as pharmaceuticals, agriculture, or environmental science, may need an introduction to the field to understand key concepts, technologies, and their applications.
• Healthcare Professionals: Doctors, nurses, and medical researchers who are starting to work with new biotech-based treatments, diagnostic tools, or genetic therapies may need introductory training on the biotechnology principles behind these innovations.

3. When Transitioning into Biotechnology Fields:

• Career Switchers: Professionals from other fields (e.g., engineering, business, or even law) who wish to transition into the biotechnology sector may need an introductory understanding of biotechnology to grasp the technical aspects of the field before pursuing more advanced training or roles.
• Entrepreneurs and Business Leaders: Business professionals entering the biotech industry need to understand the basics of biotechnology to make informed decisions on investments, partnerships, and product development.

4. At the Introduction of New Technologies or Innovations:

• New Product Development: When working on the development of new biotech products (e.g., pharmaceuticals, genetically modified crops, biofuels), professionals in the field need an understanding of biotechnology to grasp the technical requirements and potential applications.
• Regulatory or Policy Changes: Policymakers and regulators may need an introduction to biotechnology when new regulations, ethical concerns, or technological advancements are introduced in industries like healthcare, agriculture, or food safety.

5. In Response to Societal or Environmental Needs:

• Environmental Management: Environmental activists, engineers, and sustainability professionals may require biotechnology knowledge when dealing with new biotech solutions for waste management, pollution control, or bioremediation.
• Public Health Initiatives: Health authorities and policymakers may seek an introduction to biotechnology when addressing public health challenges through biotechnology-based vaccines, diagnostics, or therapies (especially in response to pandemics or disease outbreaks).

6. For Lifelong Learning and Continuing Education:

• Professional Development: Professionals already working in industries like healthcare, agriculture, or environmental science may need periodic updates on biotechnology innovations as the field evolves. Introductory courses or workshops provide the foundational knowledge to keep up with new trends, technologies, and regulatory issues.
• General Public Awareness: Consumers and individuals may need an introduction to biotechnology at any stage to better understand the products they use (e.g., genetically modified foods, pharmaceuticals) and the impact of biotechnological advancements on their daily lives.

Conclusion:

An introduction to biotechnology is required whenever individuals are starting their education or career in the field, transitioning into biotechnology-related roles, dealing with innovations and societal challenges, or seeking ongoing professional development. It is essential for anyone working or engaging with the biotechnology sector to have this foundational understanding to navigate the complexities and opportunities within the industry.

Which is required introduction to Biotechnology ?

An Introduction to Biotechnology is required for a variety of individuals, groups, and professions, depending on their interests and career goals. Here are the key audiences who would benefit from an introduction to biotechnology:

1. Students in Relevant Fields:

• High School Students: Those pursuing science courses or considering careers in life sciences, engineering, healthcare, or agriculture.
• Undergraduate Students: Those studying biotechnology, bioengineering, biology, molecular biology, biochemistry, environmental science, or agricultural science.
• Graduate Students: Postgraduate students working on advanced studies in biotechnology, genetic engineering, biomedical sciences, or related fields.

2. Professionals Starting or Transitioning into Biotech:

• Scientists and Researchers: Individuals entering or transitioning into research roles in biotechnology, genetics, microbiology, or bioengineering.
• Healthcare Professionals: Doctors, nurses, medical researchers, and technicians who will be involved with biotechnology applications such as gene therapies, diagnostic tools, and biopharmaceuticals.
• Agricultural Professionals: Farmers, agronomists, and agricultural engineers involved in genetically modified crops, pest-resistant plants, or biofuels.
• Environmental Scientists: Those working on sustainable solutions, pollution control, and bioremediation in environmental biotechnology.
• Business and Industry Leaders: Entrepreneurs, investors, and executives entering the biotechnology sector need a basic understanding of the field to make informed decisions on innovations, partnerships, and product development.

3. Policy Makers and Regulators:

• Government Officials: Individuals involved in creating laws, regulations, and guidelines around biotechnology, such as genetic modification, biotechnological products, and biosecurity.
• Ethics Committees: Those involved in overseeing ethical considerations related to biotechnological advances, particularly in genetic engineering, cloning, and GMOs.

4. Consumers and the General Public:

• Informed Consumers: People who want to make educated decisions about genetically modified foods, medical treatments involving biotechnology, and other biotech innovations impacting daily life.
• Environmental and Social Advocates: Individuals who wish to understand the environmental and ethical implications of biotechnology, especially in areas like sustainability, food security, and medical ethics.

5. Educators and Trainers:

• Teachers and Instructors: Educators in science, life sciences, and biotechnology who need foundational knowledge to teach these subjects at various levels.
• Corporate Trainers: Trainers who aim to educate employees about the applications and ethical considerations of biotechnology within a business or research setting.

Conclusion:

An introduction to biotechnology is necessary for anyone seeking to understand or work in the rapidly advancing field of biotechnology. It is particularly valuable for students pursuing related academic paths, professionals transitioning into biotechnology-related careers, policymakers, consumers, and educators. This foundational knowledge helps individuals navigate the complexities of biotechnology, which impacts industries such as healthcare, agriculture, food production, and environmental conservation.

How is required introduction to Biotechnology ?

An Introduction to Biotechnology is required in various ways depending on the learner’s background, goals, and the depth of understanding needed. Here are the common methods and approaches through which the introduction to biotechnology is typically delivered:

1. Academic Courses and Programs:

• High School Courses: Introductory biology or life science courses often include basic concepts of biotechnology, especially related to genetics, molecular biology, and applications in medicine or agriculture. These courses may involve simple experiments or case studies related to biotechnology.
• University Undergraduate Programs: For those pursuing degrees in biotechnology, bioengineering, molecular biology, biochemistry, or agricultural sciences, introductory courses provide a deeper understanding of biotechnology’s core concepts. These may include laboratory experiments, lectures, and theoretical learning on topics like genetic engineering, bioprocessing, and industrial applications.
• Postgraduate Courses: Advanced students in biotechnology or related fields will study biotechnology in more detail. This may involve specialized courses in medical biotechnology, industrial biotechnology, bioinformatics, and agricultural biotechnology.

2. Online Courses and Webinars:

• Massive Open Online Courses (MOOCs): Platforms like Coursera, edX, and Udemy offer introductory courses on biotechnology. These courses are often self-paced and may include videos, reading materials, and quizzes. Examples include “Introduction to Biotechnology” or “Fundamentals of Biotechnology.”
• Webinars and Workshops: Many universities, research organizations, or biotech companies host webinars or online workshops to introduce biotechnology concepts and their applications. These may be suitable for those looking for a more flexible or less formal learning format.

3. Workshops and Short-Term Training Programs:

• Industry-Specific Workshops: Biotechnology workshops are often offered by industry organizations or academic institutions. These workshops are aimed at professionals entering or working in biotech-related fields such as pharmaceuticals, environmental science, or agriculture.
• Certification Programs: Some training centers offer short-term certification programs that cover the basics of biotechnology and its applications. These programs might focus on areas like biomanufacturing, medical devices, or regulatory aspects of biotechnology.

4. Books, Articles, and Educational Resources:

• Textbooks and Reference Materials: Introductory textbooks in biotechnology often break down complex topics such as genetic engineering, PCR (Polymerase Chain Reaction), fermentation, and cloning in an understandable way. Books like “Biotechnology for Beginners” or “Introduction to Biotechnology” by William J. Thieman are great resources.
• Scientific Journals and Articles: For those looking to explore specific areas of biotechnology in greater depth, scientific journals (e.g., Nature Biotechnology, Biotechnology Advances) publish articles that discuss emerging trends, innovations, and real-world applications of biotechnology.

5. Practical Laboratory Experience:

• Hands-On Laboratory Work: In both academic and professional settings, biotechnology students often need to participate in laboratory-based experiments to understand how techniques like genetic modification, enzyme analysis, or microbial culture are performed. This hands-on experience is essential for comprehending the theoretical knowledge.
• Internships and Research Projects: Students or professionals can gain practical exposure to biotechnology by engaging in internships or research projects in academic labs or biotechnology companies. This allows them to apply what they have learned in real-world settings.

6. Online Simulations and Virtual Labs:

• Interactive Simulations: Many educational platforms offer virtual labs or simulations that allow users to experiment with biotechnology techniques in a controlled, virtual environment. This is an accessible way for beginners to learn about biotechnology without needing physical laboratory resources.
• Biotechnology Software: Software tools like gene sequencing simulators or bioinformatics programs help students and professionals learn to analyze biological data, which is an important aspect of modern biotechnology.

7. Professional Development and Continuing Education:

• Industry-Specific Certifications: Professionals in biotechnology-related fields can access continuing education programs and certifications (e.g., in molecular biology techniques, bioinformatics, or regulatory affairs). These programs provide an introduction to emerging biotechnologies and help individuals stay updated on the latest developments in the industry.
• Conferences and Networking Events: Conferences and industry events are another way to gain exposure to biotechnology concepts. While these are often geared toward professionals, introductory sessions or seminars can help newcomers get acquainted with the field.

8. Community and Peer Learning:

• Study Groups and Peer Discussions: Joining study groups, discussion forums, or online communities (like those on Reddit, LinkedIn, or specialized biotech forums) can offer peer learning opportunities. These platforms allow beginners to share knowledge, discuss concepts, and learn from others in the field.
• Mentorship: Aspiring biotechnologists can benefit from mentorship by experienced professionals who provide guidance, practical insights, and support in learning about biotechnology.

Conclusion:

An introduction to biotechnology can be acquired in various formats: academic courses, online learning platforms, workshops, practical laboratory work, books, or hands-on internships. The required method depends on the learner’s background, career goals, and the depth of knowledge they wish to gain. Whether it’s for students starting their academic journey or professionals transitioning into the biotechnology field, an introduction to biotechnology can be obtained through formal education, self-directed learning, or real-world experience.

Case study is introduction to Biotechnology ?

A case study can be a valuable component of an Introduction to Biotechnology, but it is not the introduction itself. Instead, case studies are specific examples used to illustrate how biotechnology is applied in real-world scenarios. They provide practical insights into how the concepts, techniques, and innovations in biotechnology are used to solve problems or create advancements in various industries.

How Case Studies are Used in an Introduction to Biotechnology:

In an introductory biotechnology course or learning module, case studies are often used to:

1. Provide Real-World Context: Case studies help students understand the real-world applications of biotechnology by showing how it is used in industries such as healthcare, agriculture, food production, and environmental management.
2. Illustrate Biotechnology Techniques: Case studies often describe specific biotechnological processes (e.g., gene editing, fermentation, or DNA sequencing) and how these techniques are applied to achieve particular outcomes.
3. Demonstrate Challenges and Ethical Considerations: They often address the ethical, social, and regulatory issues surrounding biotechnology, such as the controversy over genetically modified organisms (GMOs) or the use of CRISPR technology.
4. Highlight Innovation and Problem Solving: Case studies showcase how biotechnology is used to address pressing global issues, such as creating vaccines, developing sustainable agricultural practices, or cleaning up environmental pollutants.

Examples of Case Studies in an Introduction to Biotechnology:

1. Medical Biotechnology: A case study on the development of insulin using recombinant DNA technology to treat diabetes, highlighting the steps taken to genetically modify bacteria to produce human insulin.
2. Agricultural Biotechnology: A case study on genetically modified crops, such as Bt cotton, which are engineered to resist pests, and how this innovation has impacted agriculture and food production.
3. Environmental Biotechnology: A case study on the use of microorganisms to clean up oil spills, known as bioremediation, which demonstrates biotechnology’s potential in environmental protection.
4. Pharmaceutical Biotechnology: A case study on the development of the mRNA vaccines for COVID-19, showing how biotechnology played a key role in rapid vaccine development during the pandemic.

Conclusion:

While a case study is not an introduction to biotechnology on its own, it serves as an essential teaching tool to make the subject more tangible and relatable. Case studies enhance the learning experience by providing examples of biotechnology applications, challenges, and ethical considerations, making the introduction to biotechnology more practical and engaging for students or professionals new to the field.

White paper on introduction to Biotechnology ?

White Paper on Introduction to Biotechnology

Executive Summary

Biotechnology is a rapidly advancing field that harnesses biological systems, organisms, or derivatives to develop or create products and solutions that address challenges across healthcare, agriculture, environmental sustainability, and other industries. The importance of biotechnology is growing as it contributes to innovations in medicine, food security, and environmental conservation. This white paper provides an introduction to biotechnology, highlighting its key principles, applications, impact, and ethical considerations. It aims to offer a foundational understanding of biotechnology for policymakers, professionals, students, and the general public.

1. What is Biotechnology?

Biotechnology is the application of biological systems or organisms to develop or create products that benefit human society. It involves the use of living organisms, such as bacteria, yeast, and plants, or their components (like enzymes or DNA) to solve problems or create products for medical, industrial, agricultural, or environmental use.

Key areas of biotechnology include:

• Medical Biotechnology: Involves the development of drugs, vaccines, diagnostic tests, and therapies using biological materials.
• Agricultural Biotechnology: Involves genetic modification of plants and animals to improve yield, resistance to pests, and nutritional content.
• Environmental Biotechnology: Uses microorganisms to clean up pollutants and waste through processes like bioremediation.
• Industrial Biotechnology: Involves the use of enzymes and microorganisms in industrial processes, such as biofuels production or the fermentation industry.

2. Key Principles and Technologies

The core of biotechnology is rooted in various scientific principles and technologies that allow scientists to manipulate biological systems. Some of these key principles include:

• Genetic Engineering: The modification of an organism’s DNA to achieve desirable traits. Techniques like CRISPR-Cas9, recombinant DNA technology, and gene cloning are widely used to insert or alter genes in organisms for specific purposes.
• Fermentation: The use of microorganisms like yeast or bacteria to produce bio-based products such as alcohol, antibiotics, or biofuels.
• Cell Culture: The process of growing cells outside their natural environment to study cellular processes or to produce proteins, antibodies, or vaccines.
• Bioprocessing: The use of biological materials, such as enzymes or cells, to manufacture products on a large scale.
• Bioinformatics: The application of computational tools to analyze biological data, especially for sequencing genomes, studying proteins, and understanding metabolic pathways.

3. Applications of Biotechnology

Biotechnology impacts several industries by providing innovative solutions and addressing key global challenges. Below are some prominent applications:

• Healthcare and Medicine:
  • Drug Development: Biotechnology plays a pivotal role in the development of biopharmaceuticals and vaccines. For example, monoclonal antibodies and personalized medicine, which are customized based on an individual’s genetic profile, have become essential in modern medical treatments.
  • Gene Therapy: This approach seeks to treat or prevent diseases by inserting or altering genes within an individual’s cells, offering potential cures for genetic disorders like cystic fibrosis and muscular dystrophy.
  • Diagnostics: Biotechnology allows for the creation of sophisticated diagnostic tools, such as PCR tests for detecting infections or genetic disorders.
• Agriculture:
  • Genetically Modified Crops: Crops engineered for increased resistance to pests, diseases, or environmental stressors, such as drought or salinity, are a major breakthrough. Bt cotton, which is resistant to certain pests, is a widely known example.
  • Biofertilizers and Biopesticides: These sustainable alternatives to traditional chemical fertilizers and pesticides help improve crop yields while reducing environmental impact.
• Environmental Sustainability:
  • Bioremediation: Biotechnology helps in cleaning up environmental pollutants, such as oil spills, by using microorganisms to break down toxic substances.
  • Waste Treatment: Biotechnology is used in sewage treatment plants to digest organic matter, contributing to water purification.
  • Bioenergy: The development of renewable energy sources like biofuels, produced from plants and algae, offers a sustainable alternative to fossil fuels.
• Industrial Biotechnology:
  • Enzyme Production: Enzymes produced through biotechnology are used in various industries, including textiles, food and beverages, and detergents.
  • Biodegradable Plastics: Biotechnology also offers solutions for producing sustainable materials, such as biodegradable plastics made from renewable sources.

4. Ethical, Social, and Regulatory Considerations

While biotechnology offers many benefits, it also presents ethical and societal challenges that need to be addressed:

• Ethical Issues in Genetic Modification: Genetic engineering, especially in humans and animals, raises concerns about safety, unintended consequences, and ethical implications, such as designer babies and animal welfare.
• Environmental Impact of GMOs: The release of genetically modified organisms (GMOs) into the environment is contentious due to concerns about ecological balance, gene flow between crops and wild species, and the impact on biodiversity.
• Access to Biotechnology: There are concerns about the equitable distribution of biotechnological advances. For instance, access to gene therapies or agricultural biotechnology might be limited by socioeconomic factors or regulatory barriers.
• Regulations and Oversight: Governments and regulatory bodies like the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) regulate the approval of biotech products to ensure safety, efficacy, and ethical compliance. The balance between innovation and regulation is crucial for minimizing risks while enabling growth in the biotech sector.

5. The Future of Biotechnology

Biotechnology continues to evolve, with several promising areas on the horizon:

• Synthetic Biology: The creation of artificial life forms or organisms with entirely synthetic genomes may revolutionize industries such as medicine, agriculture, and materials science.
• Gene Editing and CRISPR: Continued advancements in gene editing technologies like CRISPR-Cas9 promise precise and efficient gene manipulation, which could lead to breakthroughs in treating genetic diseases and enhancing agricultural productivity.
• Personalized Medicine: The integration of biotechnology with genomics and data science will make medicine more individualized, offering tailored treatments based on a person’s unique genetic makeup.

6. Conclusion

Biotechnology is a dynamic field that holds immense potential for solving some of the world’s most pressing challenges, from healthcare to environmental sustainability. It is an interdisciplinary field that blends biology, chemistry, engineering, and technology to improve lives and industries globally. As biotechnology continues to evolve, it will be critical to navigate the ethical, environmental, and social implications, ensuring that innovations benefit society in a responsible and sustainable manner.

7. Recommendations

• Educational Investment: Governments, educational institutions, and companies should invest in biotechnology education and training to build a skilled workforce capable of advancing biotechnological innovations.
• Public Awareness and Engagement: Clear communication about the benefits and risks of biotechnology should be encouraged, ensuring that the public can make informed decisions about its applications.
• Global Cooperation: International collaboration is essential for addressing global challenges through biotechnology, from health crises to environmental threats.

This white paper aims to provide a comprehensive introduction to biotechnology, showcasing its vast potential and the importance of responsible development and application of biotechnological advances.

Industrial application of introduction to Biotechnology ?

Industrial Applications of Biotechnology: An Introduction

Biotechnology plays a crucial role across various industries by using biological systems, organisms, or their derivatives to develop products and solutions that improve processes and meet industrial needs. The industrial applications of biotechnology are vast and diverse, ranging from pharmaceuticals and agriculture to environmental management and energy production. This section highlights key industrial sectors where biotechnology is applied.

1. Pharmaceutical and Healthcare Industry

Biotechnology has revolutionized the pharmaceutical and healthcare industries by enabling the development of more targeted, effective, and sustainable medicines and therapies.

• Biopharmaceuticals: Biotechnology enables the production of biopharmaceuticals, which are drugs made using living organisms, cells, or enzymes. Examples include monoclonal antibodies, insulin, and vaccines. Recombinant DNA technology allows for the production of human insulin in bacteria, which is used to treat diabetes.
• Gene Therapy: Biotechnology has facilitated gene therapy, where specific genes are inserted or modified within a patient’s cells to treat genetic disorders such as cystic fibrosis, muscular dystrophy, and certain types of cancer.
• Vaccines: Biotechnology has enabled the rapid production of vaccines, including mRNA vaccines for diseases like COVID-19, demonstrating how biotechnological methods can be used to create effective treatments during health crises.
• Diagnostics: Diagnostic tools developed using biotechnology, such as PCR (Polymerase Chain Reaction), allow for the rapid detection of genetic diseases, infections, and conditions like cancer.

2. Agricultural Biotechnology

Agricultural biotechnology focuses on improving crop yields, resistance to diseases and pests, and nutritional content, as well as reducing the environmental impact of farming practices.

• Genetically Modified Organisms (GMOs): GMOs are plants or animals that have been altered through genetic engineering. For example, Bt crops (e.g., Bt cotton, Bt corn) are engineered to resist specific pests, reducing the need for chemical pesticides.
• Transgenic Crops: Crops can be modified for improved characteristics, such as drought resistance, herbicide tolerance, and enhanced nutritional content. For example, Golden Rice has been engineered to contain higher levels of vitamin A, aiming to reduce malnutrition in developing countries.
• Biopesticides and Biofertilizers: Biotechnology enables the development of biopesticides and biofertilizers, which are natural, environmentally friendly alternatives to chemical pesticides and fertilizers. These can help increase crop yields while reducing the ecological footprint of farming.
• Animal Biotechnology: Biotechnology also applies to animal breeding, helping improve livestock for better disease resistance, higher milk production, and better meat quality.

3. Environmental Biotechnology

Environmental biotechnology involves the use of biological systems to address environmental challenges, such as pollution, waste management, and sustainable resource use.

• Bioremediation: This process involves using microorganisms, plants, or fungi to break down or detoxify hazardous substances like oil spills, heavy metals, and industrial waste. For example, oil-eating bacteria are used to clean up oil spills in oceans and rivers.
• Wastewater Treatment: Biotechnology plays a role in the treatment of wastewater, using bacteria and other microorganisms to break down organic matter in sewage and industrial waste. This helps purify water, making it suitable for reuse or safe discharge.
• Bioenergy: Biotechnology enables the production of renewable energy sources such as biofuels (e.g., ethanol, biodiesel) from organic materials like crops, algae, and waste. Algal biofuel production is a promising area due to algae’s high yield and efficiency in producing oils that can be converted into biofuels.
• Biodegradable Plastics: Biotechnology is used to produce biodegradable plastics from renewable resources, which can reduce the environmental impact of conventional plastic waste. PHA (Polyhydroxyalkanoates) plastics are an example of bioplastics produced using microbial fermentation.

4. Industrial Biotechnology

Industrial biotechnology, also known as white biotechnology, applies biological processes to industrial manufacturing, replacing traditional chemical processes with biological alternatives to improve efficiency, sustainability, and cost-effectiveness.

• Fermentation: Fermentation is one of the oldest applications of biotechnology, used in the production of a wide range of industrial products. This includes alcoholic beverages, biopharmaceuticals, and enzymes. It is also used in the production of biofuels like ethanol from crops such as corn or sugarcane.
• Enzyme Production: Enzymes produced through biotechnology are used in various industries, including food processing, textiles, detergents, and biofuel production. Enzymes can be more efficient and environmentally friendly than traditional chemical catalysts.
• Biocatalysis: The use of natural catalysts, such as protein enzymes, to perform chemical reactions that are typically carried out using harsh chemicals. Biocatalysis is used in pharmaceutical manufacturing, food production, and biofuels.
• Biochemical Manufacturing: Industrial biotechnology enables the production of bulk chemicals, such as organic acids (e.g., citric acid, lactic acid), amino acids, and vitamins, using fermentation processes. These products are vital in various industries, including food, cosmetics, and pharmaceuticals.

5. Energy and Biofuels

Biotechnology is increasingly being used to produce renewable energy sources, providing alternatives to fossil fuels and contributing to a sustainable energy future.

• Biofuels: Biofuels like ethanol and biodiesel are produced from organic matter such as crops (corn, sugarcane) or algae. Biotechnology enhances the efficiency of biofuel production, enabling higher yields and better utilization of feedstocks.
• Biogas: The anaerobic digestion of organic waste to produce biogas, primarily composed of methane, is an important renewable energy source. This process is used in wastewater treatment plants and landfill sites to generate energy.
• Algal Biofuels: Research into using algae for biofuel production holds great promise because algae grow rapidly and produce high amounts of lipids that can be converted into biodiesel.

6. Food Biotechnology

Food biotechnology involves using biotechnology to improve food production, safety, and quality. It is crucial in meeting the global food demand, reducing food waste, and enhancing nutritional value.

• Food Preservation: Biotechnology plays a role in extending the shelf life of foods through the use of natural preservatives, enzymes, and probiotics. For example, lactic acid bacteria are used to ferment dairy products and produce beneficial probiotics.
• Food Additives: Biotechnology is used to produce food additives such as enzymes, flavor enhancers, and colorants. These biotechnologically derived substances can replace synthetic chemicals in food production, providing safer and more natural alternatives.
• Improved Food Crops: Genetically modified crops with improved nutritional profiles (such as golden rice) or enhanced resistance to spoilage are increasingly used to meet the growing global food demand.

7. Textile and Paper Industry

Biotechnology is also making an impact on industries like textiles and paper production, where biological processes are used to enhance the manufacturing process and reduce environmental impact.

• Enzyme Washing: In textile manufacturing, enzymes are used to soften and finish fabrics, reducing the need for harsh chemicals and improving the quality of fabrics.
• Biodegradable Paper: Biotechnology can be used to produce paper from agricultural residues or other plant fibers, which can be broken down more easily after use, reducing waste.

Conclusion

The industrial applications of biotechnology are diverse and growing. From healthcare and agriculture to environmental sustainability and energy production, biotechnology offers solutions that help industries become more efficient, sustainable, and innovative. As biotechnology continues to evolve, its applications will likely expand, offering new ways to tackle global challenges such as food security, climate change, and health care.

Research and development of introduction to Biotechnology ?

Research and Development (R&D) in Biotechnology: An Introduction

The field of biotechnology is driven by continuous research and development (R&D), which plays a pivotal role in advancing the science and technology behind it. R&D in biotechnology focuses on discovering new biological systems, processes, and innovations that can be applied across a wide range of industries, including healthcare, agriculture, environmental management, and industrial production. This section explores the R&D landscape within biotechnology, including its significance, processes, and key areas of focus.

1. Significance of R&D in Biotechnology

Biotechnology R&D is crucial for several reasons:

• Advancing Scientific Knowledge: Biotechnology is a rapidly evolving field, and ongoing research is essential for understanding the underlying biological processes and mechanisms at play. R&D provides insights into how organisms function, how genetic material can be manipulated, and how biological systems can be harnessed for practical applications.
• Innovation in Products and Technologies: R&D enables the development of innovative products and technologies, such as genetically modified organisms (GMOs), biopharmaceuticals, and sustainable biofuels. Without continuous research, the biotech industry would be unable to meet the growing global demand for advanced solutions in healthcare, agriculture, and environmental sustainability.
• Improvement in Efficiency and Sustainability: Research in biotechnology often leads to the development of more efficient processes that use fewer resources, produce fewer waste products, and have less environmental impact. This is particularly important in industries like agriculture, energy, and pharmaceuticals.
• Addressing Global Challenges: Biotechnology R&D is at the forefront of solving pressing global challenges, such as food security, climate change, infectious diseases, and energy sustainability. Advances in biotechnology allow for the development of new treatments, more resilient crops, and alternative energy sources.

2. Key Areas of R&D in Biotechnology

Biotechnology R&D encompasses a broad spectrum of fields, each contributing to advances in various sectors. Key areas of research and development include:

A. Genomic and Genetic Engineering

• Gene Editing Technologies: One of the most significant advancements in biotechnology is the development of gene-editing technologies such as CRISPR-Cas9. Researchers are exploring how to precisely edit the DNA of organisms to correct genetic defects, enhance traits in crops and animals, and create novel therapeutic interventions for genetic diseases.
• Synthetic Biology: Synthetic biology involves redesigning biological systems or creating entirely new biological systems from scratch. R&D in synthetic biology includes developing microorganisms or cells that can produce valuable chemicals, biofuels, and pharmaceuticals. It aims to create “biological machines” that perform specific functions, such as targeted drug delivery.

B. Biopharmaceuticals and Medicine

• Monoclonal Antibodies: R&D in biotechnology has led to the production of monoclonal antibodies for the treatment of diseases like cancer, autoimmune disorders, and infections. Researchers are focusing on enhancing the specificity and effectiveness of these treatments, as well as developing next-generation antibody therapies, including bispecific antibodies and CAR-T cell therapies for cancer.
• Vaccines: Biotechnology R&D is key to the development of new vaccines. The rapid creation of mRNA vaccines for COVID-19, for instance, demonstrated the potential for biotechnology to quickly respond to emerging infectious diseases. Researchers continue to focus on creating vaccines for a range of diseases, including HIV, malaria, and cancer.
• Gene Therapy and Personalized Medicine: Gene therapy aims to treat diseases by replacing or repairing faulty genes. Research in personalized medicine is also growing, where treatments are tailored to an individual’s genetic makeup, enhancing their efficacy and minimizing side effects.

C. Agricultural Biotechnology

• Genetically Modified Crops: R&D in agricultural biotechnology focuses on creating crops with improved yields, resistance to pests, tolerance to environmental stress, and enhanced nutritional content. Golden Rice, which has been engineered to produce higher levels of vitamin A, is one example of how genetic engineering can address nutritional deficiencies in developing countries.
• CRISPR in Crops: The application of CRISPR gene-editing technology in agriculture has shown promise in creating crops with better disease resistance, faster growth rates, and improved nutritional content. Researchers are exploring the potential of CRISPR to enhance crop productivity in the face of climate change and growing global food demand.
• Biopesticides and Biofertilizers: R&D is also directed toward developing environmentally friendly alternatives to chemical pesticides and fertilizers, using natural organisms or biotechnological processes to control pests and enhance soil fertility.

D. Environmental Biotechnology

• Bioremediation: Research is ongoing in the field of bioremediation, where microorganisms, plants, or enzymes are used to clean up pollutants from soil, water, and air. Scientists are working to enhance the capabilities of certain microorganisms to break down toxins more effectively and in a shorter time frame.
• Carbon Sequestration: Biotechnology R&D is exploring how to use biological processes to capture and store carbon dioxide, helping to mitigate climate change. Certain plants, algae, and bacteria have been identified as potential agents for carbon sequestration.
• Waste-to-Energy: R&D in biotechnology focuses on converting organic waste materials into energy through anaerobic digestion and other biological processes. This includes the development of biogas and biofuels from agricultural and industrial waste.

E. Industrial Biotechnology

• Fermentation and Enzyme Technology: Industrial biotechnology R&D focuses on improving fermentation processes to produce bulk chemicals, biofuels, and biopharmaceuticals. Researchers are also developing enzymes that can catalyze reactions more efficiently in industrial applications, from food production to textile manufacturing.
• Bio-based Plastics: R&D is underway to produce biodegradable plastics from renewable sources like plant starch or algae. This biotechnology development addresses the environmental issues caused by conventional petroleum-based plastics.
• Biofuels: As the demand for alternative energy sources increases, biotechnology R&D is working to enhance the production of biofuels, such as ethanol, biodiesel, and algae-based biofuels. Researchers are focusing on improving feedstock efficiency, reducing costs, and increasing yield.

3. Collaboration and Funding in Biotechnology R&D

Biotechnology R&D often involves collaboration between academic institutions, research organizations, government agencies, and private companies. These partnerships facilitate the sharing of resources, knowledge, and expertise.

• Public-Private Partnerships: Public funding for biotechnology research is often complemented by investments from private industry, particularly in areas like drug development and agricultural biotechnology. Companies benefit from public funding through government grants and tax incentives for R&D.
• Venture Capital: Biotechnology startups and emerging companies often rely on venture capital to fund their research efforts. Venture capital plays a crucial role in taking biotechnology innovations from the laboratory to commercialization.
• Government and Regulatory Support: Government agencies, such as the National Institutes of Health (NIH) in the U.S. and the European Commission, fund biotechnology research and provide regulatory frameworks that guide the development and commercialization of new biotechnology products.

4. Ethical Considerations in Biotechnology R&D

While R&D in biotechnology has the potential to yield transformative solutions, it also raises ethical and societal concerns. Issues include:

• Genetic Modification: The modification of genes in humans, animals, and plants raises ethical questions about the potential unintended consequences and the long-term impacts on biodiversity.
• Access and Equity: As biotechnology advances, there is a concern about equitable access to its benefits. Ensuring that new biotechnology products and treatments are affordable and accessible to all, especially in developing countries, is a major ethical issue.
• Environmental Impact: The release of genetically modified organisms (GMOs) or bioengineered products into the environment may have unforeseen ecological consequences, necessitating careful evaluation and regulation.

Conclusion

R&D is the backbone of biotechnology, driving continuous innovation and discovery in fields that impact virtually every aspect of human life. As biotechnology evolves, R&D will continue to play a critical role in solving global challenges, improving human health, ensuring food security, and promoting environmental sustainability. However, ethical considerations and responsible research practices must guide the development of biotechnological innovations to ensure that the benefits of this field are realized in a safe, equitable, and sustainable manner.

Courtesy : Competition Wallah

References

^ “Biotechnology”. IUPAC Goldbook. 2014. doi:10.1351/goldbook.B00666. Archived from the original on January 20, 2022. Retrieved February 14, 2022.

^ Ereky, Karl. (June 8, 1919). Biotechnologie der Fleisch-, Fett-, und Milcherzeugung im landwirtschaftlichen Grossbetriebe: für naturwissenschaftlich gebildete Landwirte verfasst. P. Parey. Archived from the original on March 5, 2016. Retrieved March 16, 2022 – via Hathi Trust.

^ “Genetic Engineering”. National Human Genome Research Institute, US National Institutes of Health. December 15, 2023. Retrieved December 18, 2023.

^ Gupta, Varsha; Sengupta, Manjistha; Prakash, Jaya; Tripathy, Baishnab Charan (October 23, 2016). “An Introduction to Biotechnology”. Basic and Applied Aspects of Biotechnology. pp. 1–21. doi:10.1007/978-981-10-0875-7_1. ISBN 978-981-10-0873-3. PMC 7119977.

^ O’Mathúna, Dónal P. (April 1, 2007). “Bioethics and biotechnology”. Cytotechnology. 53 (1–3): 113–119. doi:10.1007/s10616-007-9053-8. ISSN 0920-9069. PMC 2267612. PMID 19003197.

^ “Biotechnology”. portal.acs.org. American Chemical Society. Archived from the original on November 7, 2012. Retrieved March 20, 2013.

^ “BIOTECHNOLOGY-PRINCIPLES & PROCESSES” (PDF). Archived from the original (PDF) on August 7, 2015. Retrieved December 29, 2014.

^ What is biotechnology?. Europabio. Retrieved on March 20, 2013.

^ Key Biotechnology Indicators (December 2011) Archived November 8, 2012, at the Wayback Machine. oecd.org

^ “Biotechnology policies” – Organization for Economic Co-operation and Development. Archived August 31, 2012, at the Wayback Machine. Retrieved on March 20, 2013.

^ Goli, Divakar; Bhatia, Saurabh (May 2018). History, scope and development of biotechnology. IOPscience. doi:10.1088/978-0-7503-1299-8ch1. ISBN 978-0-7503-1299-8.

^ What Is Bioengineering? Archived January 23, 2013, at the Wayback Machine. Bionewsonline.com. Retrieved on March 20, 2013.

^ See Arnold JP (2005). Origin and History of Beer and Brewing: From Prehistoric Times to the Beginning of Brewing Science and Technology. Cleveland, Ohio: BeerBooks. p. 34. ISBN 978-0-9662084-1-2. OCLC 71834130..

^ Cole-Turner R (2003). “Biotechnology”. Encyclopedia of Science and Religion. Archived from the original on October 25, 2009. Retrieved December 7, 2014.

^ Jump up to:^a b Thieman WJ, Palladino MA (2008). Introduction to Biotechnology. Pearson/Benjamin Cummings. ISBN 978-0-321-49145-9.

^ Springham D, Springham G, Moses V, Cape RE (1999). Biotechnology: The Science and the Business. CRC Press. p. 1. ISBN 978-90-5702-407-8.

^ “Diamond v. Chakrabarty, 447 U.S. 303 (1980). No. 79-139 Archived June 28, 2011, at the Wayback Machine.” United States Supreme Court. June 16, 1980. Retrieved on May 4, 2007.

^ US2802760A, Lincoln, Derick & Frosch, Carl J., “Oxidation of semiconductive surfaces for controlled diffusion”, issued 1957-08-13

^ Huff, Howard; Riordan, Michael (September 1, 2007). “Frosch and Derick: Fifty Years Later (Foreword)”. The Electrochemical Society Interface. 16 (3): 29. doi:10.1149/2.F02073IF. ISSN 1064-8208.

^ Frosch, C. J.; Derick, L (1957). “Surface Protection and Selective Masking during Diffusion in Silicon”. Journal of the Electrochemical Society. 104 (9): 547. doi:10.1149/1.2428650.

^ KAHNG, D. (1961). “Silicon-Silicon Dioxide Surface Device”. Technical Memorandum of Bell Laboratories: 583–596. doi:10.1142/9789814503464_0076. ISBN 978-981-02-0209-5.

^ Lojek, Bo (2007). History of Semiconductor Engineering. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg. p. 321. ISBN 978-3-540-34258-8.

^ Lojek, Bo (2007). History of Semiconductor Engineering. Springer Science & Business Media. p. 120. ISBN 9783540342588.

^ Park, Jeho; Nguyen, Hoang Hiep; Woubit, Abdela; Kim, Moonil (2014). “Applications of Field-Effect Transistor (FET)–Type Biosensors”. Applied Science and Convergence Technology. 23 (2): 61–71. doi:10.5757/ASCT.2014.23.2.61. ISSN 2288-6559. S2CID 55557610.

^ Clark, Leland C.; Lyons, Champ (1962). “Electrode Systems for Continuous Monitoring in Cardiovascular Surgery”. Annals of the New York Academy of Sciences. 102 (1): 29–45. Bibcode:1962NYASA.102…29C. doi:10.1111/j.1749-6632.1962.tb13623.x. ISSN 1749-6632. PMID 14021529. S2CID 33342483.

^ Jump up to:^a b c Bergveld, Piet (October 1985). “The impact of MOSFET-based sensors” (PDF). Sensors and Actuators. 8 (2): 109–127. Bibcode:1985SeAc….8..109B. doi:10.1016/0250-6874(85)87009-8. ISSN 0250-6874. Archived (PDF) from the original on October 9, 2022.

^ Chris Toumazou; Pantelis Georgiou (December 2011). “40 years of ISFET technology:From neuronal sensing to DNA sequencing”. Electronics Letters. Retrieved May 13, 2016.

^ Bergveld, P. (January 1970). “Development of an Ion-Sensitive Solid-State Device for Neurophysiological Measurements”. IEEE Transactions on Biomedical Engineering. BME-17 (1): 70–71. doi:10.1109/TBME.1970.4502688. PMID 5441220.

^ Jump up to:^a b c Schöning, Michael J.; Poghossian, Arshak (September 10, 2002). “Recent advances in biologically sensitive field-effect transistors (BioFETs)” (PDF). Analyst. 127 (9): 1137–1151. Bibcode:2002Ana…127.1137S. doi:10.1039/B204444G. ISSN 1364-5528. PMID 12375833. Archived (PDF) from the original on October 9, 2022.

^ VoIP Providers And Corn Farmers Can Expect To Have Bumper Years In 2008 And Beyond, According To The Latest Research Released By Business Information Analysts At IBISWorld. Los Angeles (March 19, 2008)

^ “The Recession List – Top 10 Industries to Fly and Flop in 2008”. Bio-Medicine.org. March 19, 2008. Archived from the original on June 2, 2008. Retrieved May 19, 2008.

^ Amarakoon, Icolyn; Hamilton, Cindy; Mitchell, Sylvia; Tennant, Paula; Roye, Marcia (October 20, 2023). “Biotechnology: principles and applications”. Pharmacognosy: 627–645. doi:10.1016/b978-0-443-18657-8.00017-7. Retrieved November 1, 2024.

^ Gerstein, M. “Bioinformatics Introduction Archived 2007-06-16 at the Wayback Machine.” Yale University. Retrieved on May 8, 2007.

^ Siam, R. (2009). Biotechnology Research and Development in Academia: providing the foundation for Egypt’s Biotechnology spectrum of colors. Sixteenth Annual American University in Cairo Research Conference, American University in Cairo, Cairo, Egypt. BMC Proceedings, 31–35.

^ Jump up to:^{a b c d e f g h i j k l m} Kafarski, P. (2012). Rainbow Code of Biotechnology Archived February 14, 2019, at the Wayback Machine. CHEMIK. Wroclaw University

^ Biotech: true colours. (2009). TCE: The Chemical Engineer, (816), 26–31.

^ Aldridge, S. (2009). The four colours of biotechnology: the biotechnology sector is occasionally described as a rainbow, with each sub sector having its own colour. But what do the different colours of biotechnology have to offer the pharmaceutical industry. Pharmaceutical Technology Europe, (1). 12.

^ Frazzetto G (September 2003). “White biotechnology”. EMBO Reports. 4 (9): 835–7. doi:10.1038/sj.embor.embor928. PMC 1326365. PMID 12949582.

^ Frazzetto, G. (2003). White biotechnology Archived November 11, 2018, at the Wayback Machine. March 21, 2017, de EMBOpress Sitio

^ Advances in Biochemical Engineering/Biotechnology Archived July 19, 2018, at the Wayback Machine, Volume 135 2013, Yellow Biotechnology I

^ Santomartino R, Averesch NJ, Bhuiyan M, Cockell CS, Colangelo J, Gumulya Y, Lehner B, Lopez-Ayala I, McMahon S, Mohanty A, Santa Maria SR, Urbaniak C, Volger R, Yang J, Zea L (March 2023). “Toward sustainable space exploration: a roadmap for harnessing the power of microorganisms”. Nature Communications. 14 (1): 1391. Bibcode:2023NatCo..14.1391S. doi:10.1038/s41467-023-37070-2. PMC 10030976. PMID 36944638.

^ Edgar, J.D. (2004). The Colours of Biotechnology: Science, Development and Humankind. Electronic Journal of Biotechnology, (3), 01

^ “Top Global Pharmaceutical Company Report” (PDF). The Pharma 1000. November 2021. Archived (PDF) from the original on March 15, 2022. Retrieved December 29, 2022.

^ Ermak G. (2013) Modern Science & Future Medicine (second edition)

^ Wang L (2010). “Pharmacogenomics: a systems approach”. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2 (1): 3–22. doi:10.1002/wsbm.42. PMC 3894835. PMID 20836007.

^ Becquemont L (June 2009). “Pharmacogenomics of adverse drug reactions: practical applications and perspectives”. Pharmacogenomics. 10 (6): 961–9. doi:10.2217/pgs.09.37. PMID 19530963.

^ “Guidance for Industry Pharmacogenomic Data Submissions” (PDF). U.S. Food and Drug Administration. March 2005. Archived (PDF) from the original on October 9, 2022. Retrieved August 27, 2008.

^ Squassina A, Manchia M, Manolopoulos VG, Artac M, Lappa-Manakou C, Karkabouna S, Mitropoulos K, Del Zompo M, Patrinos GP (August 2010). “Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice”. Pharmacogenomics. 11 (8): 1149–67. doi:10.2217/pgs.10.97. PMID 20712531.

^ Bains W (1987). Genetic Engineering For Almost Everybody: What Does It Do? What Will It Do?. Penguin. p. 99. ISBN 978-0-14-013501-5.

^ Jump up to:^a b U.S. Department of State International Information Programs, “Frequently Asked Questions About Biotechnology”, USIS Online; available from USinfo.state.gov Archived September 12, 2007, at the Wayback Machine, accessed September 13, 2007. Cf. Feldbaum C (February 2002). “Biotechnology. Some history should be repeated”. Science. 295 (5557): 975. doi:10.1126/science.1069614. PMID 11834802. S2CID 32595222.

^ “What is genetic testing? – Genetics Home Reference”. Ghr.nlm.nih.gov. May 30, 2011. Archived from the original on May 29, 2006. Retrieved June 7, 2011.

^ “Genetic Testing: MedlinePlus”. Nlm.nih.gov. Archived from the original on June 8, 2011. Retrieved June 7, 2011.

^ “Definitions of Genetic Testing”. Definitions of Genetic Testing (Jorge Sequeiros and Bárbara Guimarães). EuroGentest Network of Excellence Project. September 11, 2008. Archived from the original on February 4, 2009. Retrieved August 10, 2008.

^ Genetically Altered Potato Ok’d For Crops Archived July 31, 2022, at the Wayback Machine Lawrence Journal-World – May 6, 1995

^ National Academy of Sciences (2001). Transgenic Plants and World Agriculture. Washington: National Academy Press.

^ Paarlburg R (January 2011). “Drought Tolerant GMO Maize in Africa, Anticipating Regulatory Hurdles” (PDF). International Life Sciences Institute. Archived from the original (PDF) on December 22, 2014. Retrieved April 25, 2011.

^ Carpenter J. & Gianessi L. (1999). Herbicide tolerant soybeans: Why growers are adopting Roundup Ready varieties Archived November 19, 2012, at the Wayback Machine. AgBioForum, 2(2), 65–72.

^ Haroldsen VM, Paulino G, Chi-ham C, Bennett AB (2012). “Research and adoption of biotechnology strategies could improve California fruit and nut crops”. California Agriculture. 66 (2): 62–69. doi:10.3733/ca.v066n02p62.

^ About Golden Rice Archived November 2, 2012, at the Wayback Machine. Irri.org. Retrieved on March 20, 2013.

^ Gali Weinreb and Koby Yeshayahou for Globes May 2, 2012. FDA approves Protalix Gaucher treatment Archived May 29, 2013, at the Wayback Machine

^ Carrington, Damien (January 19, 2012) GM microbe breakthrough paves way for large-scale seaweed farming for biofuels Archived May 11, 2017, at the Wayback Machine The Guardian. Retrieved March 12, 2012

^ van Beilen JB, Poirier Y (May 2008). “Production of renewable polymers from crop plants”. The Plant Journal. 54 (4): 684–701. doi:10.1111/j.1365-313X.2008.03431.x. PMID 18476872. S2CID 25954199.

^ Strange, Amy (September 20, 2011) Scientists engineer plants to eat toxic pollution Archived September 13, 2011, at the Wayback Machine The Irish Times. Retrieved September 20, 2011

^ Diaz E, ed. (2008). Microbial Biodegradation: Genomics and Molecular Biology. Caister Academic Press. ISBN 978-1-904455-17-2.

^ Jump up to:^a b c James C (2011). “ISAAA Brief 43, Global Status of Commercialized Biotech/GM Crops: 2011”. ISAAA Briefs. Ithaca, New York: International Service for the Acquisition of Agri-biotech Applications (ISAAA). Archived from the original on February 10, 2012. Retrieved June 2, 2012.

^ GM Science Review First Report Archived October 16, 2013, at the Wayback Machine, Prepared by the UK GM Science Review panel (July 2003). Chairman Professor Sir David King, Chief Scientific Advisor to the UK Government, P 9

^ James C (1996). “Global Review of the Field Testing and Commercialization of Transgenic Plants: 1986 to 1995” (PDF). The International Service for the Acquisition of Agri-biotech Applications. Archived (PDF) from the original on October 9, 2022. Retrieved July 17, 2010.

^ “Consumer Q&A”. Fda.gov. March 6, 2009. Archived from the original on January 10, 2013. Retrieved December 29, 2012.

^ “AquAdvantage Salmon”. FDA. Archived from the original on December 31, 2012. Retrieved July 20, 2018.

^ Nicolia, Alessandro; Manzo, Alberto; Veronesi, Fabio; Rosellini, Daniele (2013). “An overview of the last 10 years of genetically engineered crop safety research” (PDF). Critical Reviews in Biotechnology. 34 (1): 77–88. doi:10.3109/07388551.2013.823595. PMID 24041244. S2CID 9836802. Archived (PDF) from the original on October 9, 2022. We have reviewed the scientific literature on GE crop safety for the last 10 years that catches the scientific consensus matured since GE plants became widely cultivated worldwide, and we can conclude that the scientific research conducted so far has not detected any significant hazard directly connected with the use of GM crops.

The literature about Biodiversity and the GE food/feed consumption has sometimes resulted in animated debate regarding the suitability of the experimental designs, the choice of the statistical methods or the public accessibility of data. Such debate, even if positive and part of the natural process of review by the scientific community, has frequently been distorted by the media and often used politically and inappropriately in anti-GE crops campaigns.

^ “State of Food and Agriculture 2003–2004. Agricultural Biotechnology: Meeting the Needs of the Poor. Health and environmental impacts of transgenic crops”. Food and Agriculture Organization of the United Nations. Archived from the original on January 9, 2019. Retrieved August 30, 2019. Currently available transgenic crops and foods derived from them have been judged safe to eat and the methods used to test their safety have been deemed appropriate. These conclusions represent the consensus of the scientific evidence surveyed by the ICSU (2003) and they are consistent with the views of the World Health Organization (WHO, 2002). These foods have been assessed for increased risks to human health by several national regulatory authorities (inter alia, Argentina, Brazil, Canada, China, the United Kingdom and the United States) using their national food safety procedures (ICSU). To date no verifiable untoward toxic or nutritionally deleterious effects resulting from the consumption of foods derived from genetically modified crops have been discovered anywhere in the world (GM Science Review Panel). Many millions of people have consumed foods derived from GM plants – mainly maize, soybean and oilseed rape – without any observed adverse effects (ICSU).

^ Ronald, Pamela (May 1, 2011). “Plant Genetics, Sustainable Agriculture and Global Food Security”. Genetics. 188 (1): 11–20. doi:10.1534/genetics.111.128553. PMC 3120150. PMID 21546547. There is broad scientific consensus that genetically engineered crops currently on the market are safe to eat. After 14 years of cultivation and a cumulative total of 2 billion acres planted, no adverse health or environmental effects have resulted from commercialization of genetically engineered crops (Board on Agriculture and Natural Resources, Committee on Environmental Impacts Associated with Commercialization of Transgenic Plants, National Research Council and Division on Earth and Life Studies 2002). Both the U.S. National Research Council and the Joint Research Centre (the European Union’s scientific and technical research laboratory and an integral part of the European Commission) have concluded that there is a comprehensive body of knowledge that adequately addresses the food safety issue of genetically engineered crops (Committee on Identifying and Assessing Unintended Effects of Genetically Engineered Foods on Human Health and National Research Council 2004; European Commission Joint Research Centre 2008). These and other recent reports conclude that the processes of genetic engineering and conventional breeding are no different in terms of unintended consequences to human health and the environment (European Commission Directorate-General for Research and Innovation 2010).

^But see also:Domingo, José L.; Bordonaba, Jordi Giné (2011). “A literature review on the safety assessment of genetically modified plants” (PDF). Environment International. 37 (4): 734–742. Bibcode:2011EnInt..37..734D. doi:10.1016/j.envint.2011.01.003. PMID 21296423. Archived (PDF) from the original on October 9, 2022. In spite of this, the number of studies specifically focused on safety assessment of GM plants is still limited. However, it is important to remark that for the first time, a certain equilibrium in the number of research groups suggesting, on the basis of their studies, that a number of varieties of GM products (mainly maize and soybeans) are as safe and nutritious as the respective conventional non-GM plant, and those raising still serious concerns, was observed. Moreover, it is worth mentioning that most of the studies demonstrating that GM foods are as nutritional and safe as those obtained by conventional breeding, have been performed by biotechnology companies or associates, which are also responsible of commercializing these GM plants. Anyhow, this represents a notable advance in comparison with the lack of studies published in recent years in scientific journals by those companies.Krimsky, Sheldon (2015). “An Illusory Consensus behind GMO Health Assessment”. Science, Technology, & Human Values. 40 (6): 883–914. doi:10.1177/0162243915598381. S2CID 40855100. I began this article with the testimonials from respected scientists that there is literally no scientific controversy over the health effects of GMOs. My investigation into the scientific literature tells another story.And contrast:Panchin, Alexander Y.; Tuzhikov, Alexander I. (January 14, 2016). “Published GMO studies find no evidence of harm when corrected for multiple comparisons”. Critical Reviews in Biotechnology. 37 (2): 213–217. doi:10.3109/07388551.2015.1130684. ISSN 0738-8551. PMID 26767435. S2CID 11786594. Here, we show that a number of articles some of which have strongly and negatively influenced the public opinion on GM crops and even provoked political actions, such as GMO embargo, share common flaws in the statistical evaluation of the data. Having accounted for these flaws, we conclude that the data presented in these articles does not provide any substantial evidence of GMO harm.

The presented articles suggesting possible harm of GMOs received high public attention. However, despite their claims, they actually weaken the evidence for the harm and lack of substantial equivalency of studied GMOs. We emphasize that with over 1783 published articles on GMOs over the last 10 years it is expected that some of them should have reported undesired differences between GMOs and conventional crops even if no such differences exist in reality.andYang, Y.T.; Chen, B. (2016). “Governing GMOs in the USA: science, law and public health”. Journal of the Science of Food and Agriculture. 96 (4): 1851–1855. Bibcode:2016JSFA…96.1851Y. doi:10.1002/jsfa.7523. PMID 26536836. It is therefore not surprising that efforts to require labeling and to ban GMOs have been a growing political issue in the USA (citing Domingo and Bordonaba, 2011). Overall, a broad scientific consensus holds that currently marketed GM food poses no greater risk than conventional food… Major national and international science and medical associations have stated that no adverse human health effects related to GMO food have been reported or substantiated in peer-reviewed literature to date.

Despite various concerns, today, the American Association for the Advancement of Science, the World Health Organization, and many independent international science organizations agree that GMOs are just as safe as other foods. Compared with conventional breeding techniques, genetic engineering is far more precise and, in most cases, less likely to create an unexpected outcome.

^ “Statement by the AAAS Board of Directors On Labeling of Genetically Modified Foods” (PDF). American Association for the Advancement of Science. October 20, 2012. Archived (PDF) from the original on October 9, 2022. Retrieved August 30, 2019. The EU, for example, has invested more than €300 million in research on the biosafety of GMOs. Its recent report states: “The main conclusion to be drawn from the efforts of more than 130 research projects, covering a period of more than 25 years of research and involving more than 500 independent research groups, is that biotechnology, and in particular GMOs, are not per se more risky than e.g. conventional plant breeding technologies.” The World Health Organization, the American Medical Association, the U.S. National Academy of Sciences, the British Royal Society, and every other respected organization that has examined the evidence has come to the same conclusion: consuming foods containing ingredients derived from GM crops is no riskier than consuming the same foods containing ingredients from crop plants modified by conventional plant improvement techniques.

Pinholster, Ginger (October 25, 2012). “AAAS Board of Directors: Legally Mandating GM Food Labels Could “Mislead and Falsely Alarm Consumers”” (PDF). American Association for the Advancement of Science. Archived (PDF) from the original on October 9, 2022. Retrieved August 30, 2019.

^ European Commission. Directorate-General for Research (2010). A decade of EU-funded GMO research (2001–2010) (PDF). Directorate-General for Research and Innovation. Biotechnologies, Agriculture, Food. European Commission, European Union. doi:10.2777/97784. ISBN 978-92-79-16344-9. Archived (PDF) from the original on October 9, 2022. Retrieved August 30, 2019.

^ “AMA Report on Genetically Modified Crops and Foods”. American Medical Association. January 2001. Archived from the original on April 2, 2016. Retrieved August 30, 2019 – via International Service for the Acquisition of Agri-biotech Applications.“Report 2 of the Council on Science and Public Health (A-12): Labeling of Bioengineered Foods” (PDF). American Medical Association. 2012. Archived from the original (PDF) on September 7, 2012. Retrieved August 30, 2019.

^ “Restrictions on Genetically Modified Organisms: United States. Public and Scholarly Opinion”. Library of Congress. June 30, 2015. Archived from the original on December 30, 2019. Retrieved August 30, 2019. Several scientific organizations in the US have issued studies or statements regarding the safety of GMOs indicating that there is no evidence that GMOs present unique safety risks compared to conventionally bred products. These include the National Research Council, the American Association for the Advancement of Science, and the American Medical Association. Groups in the US opposed to GMOs include some environmental organizations, organic farming organizations, and consumer organizations. A substantial number of legal academics have criticized the US’s approach to regulating GMOs.

^ National Academies Of Sciences, Engineering; Division on Earth Life Studies; Board on Agriculture Natural Resources; Committee on Genetically Engineered Crops: Past Experience Future Prospects (2016). Genetically Engineered Crops: Experiences and Prospects. The National Academies of Sciences, Engineering, and Medicine (US). p. 149. doi:10.17226/23395. ISBN 978-0-309-43738-7. PMID 28230933. Archived from the original on November 16, 2021. Retrieved August 30, 2019. Overall finding on purported adverse effects on human health of foods derived from GE crops: On the basis of detailed examination of comparisons of currently commercialized GE with non-GE foods in compositional analysis, acute and chronic animal toxicity tests, long-term data on health of livestock fed GE foods, and human epidemiological data, the committee found no differences that implicate a higher risk to human health from GE foods than from their non-GE counterparts.

^ “Frequently asked questions on genetically modified foods”. World Health Organization. Archived from the original on November 4, 2020. Retrieved August 30, 2019. Different GM organisms include different genes inserted in different ways. This means that individual GM foods and their safety should be assessed on a case-by-case basis and that it is not possible to make general statements on the safety of all GM foods.

GM foods currently available on the international market have passed safety assessments and are not likely to present risks for human health. In addition, no effects on human health have been shown as a result of the consumption of such foods by the general population in the countries where they have been approved. Continuous application of safety assessments based on the Codex Alimentarius principles and, where appropriate, adequate post market monitoring, should form the basis for ensuring the safety of GM foods.

^ Haslberger, Alexander G. (2003). “Codex guidelines for GM foods include the analysis of unintended effects”. Nature Biotechnology. 21 (7): 739–741. doi:10.1038/nbt0703-739. PMID 12833088. S2CID 2533628. These principles dictate a case-by-case premarket assessment that includes an evaluation of both direct and unintended effects.

^ Some medical organizations, including the British Medical Association, advocate further caution based upon the precautionary principle:

“Genetically modified foods and health: a second interim statement” (PDF). British Medical Association. March 2004. Archived (PDF) from the original on October 9, 2022. Retrieved August 30, 2019. In our view, the potential for GM foods to cause harmful health effects is very small and many of the concerns expressed apply with equal vigour to conventionally derived foods. However, safety concerns cannot, as yet, be dismissed completely on the basis of information currently available.

When seeking to optimise the balance between benefits and risks, it is prudent to err on the side of caution and, above all, learn from accumulating knowledge and experience. Any new technology such as genetic modification must be examined for possible benefits and risks to human health and the environment. As with all novel foods, safety assessments in relation to GM foods must be made on a case-by-case basis.

Members of the GM jury project were briefed on various aspects of genetic modification by a diverse group of acknowledged experts in the relevant subjects. The GM jury reached the conclusion that the sale of GM foods currently available should be halted and the moratorium on commercial growth of GM crops should be continued. These conclusions were based on the precautionary principle and lack of evidence of any benefit. The Jury expressed concern over the impact of GM crops on farming, the environment, food safety and other potential health effects.

The Royal Society review (2002) concluded that the risks to human health associated with the use of specific viral DNA sequences in GM plants are negligible, and while calling for caution in the introduction of potential allergens into food crops, stressed the absence of evidence that commercially available GM foods cause clinical allergic manifestations. The BMA shares the view that there is no robust evidence to prove that GM foods are unsafe but we endorse the call for further research and surveillance to provide convincing evidence of safety and benefit.

^ Funk, Cary; Rainie, Lee (January 29, 2015). “Public and Scientists’ Views on Science and Society”. Pew Research Center. Archived from the original on January 9, 2019. Retrieved August 30, 2019. The largest differences between the public and the AAAS scientists are found in beliefs about the safety of eating genetically modified (GM) foods. Nearly nine-in-ten (88%) scientists say it is generally safe to eat GM foods compared with 37% of the general public, a difference of 51 percentage points.

^ Marris, Claire (2001). “Public views on GMOs: deconstructing the myths”. EMBO Reports. 2 (7): 545–548. doi:10.1093/embo-reports/kve142. PMC 1083956. PMID 11463731.

^ Final Report of the PABE research project (December 2001). “Public Perceptions of Agricultural Biotechnologies in Europe”. Commission of European Communities. Archived from the original on May 25, 2017. Retrieved August 30, 2019.

^ Scott, Sydney E.; Inbar, Yoel; Rozin, Paul (2016). “Evidence for Absolute Moral Opposition to Genetically Modified Food in the United States” (PDF). Perspectives on Psychological Science. 11 (3): 315–324. doi:10.1177/1745691615621275. PMID 27217243. S2CID 261060. Archived (PDF) from the original on October 9, 2022.

^ “Restrictions on Genetically Modified Organisms”. Library of Congress. June 9, 2015. Archived from the original on April 3, 2019. Retrieved August 30, 2019.

^ Bashshur, Ramona (February 2013). “FDA and Regulation of GMOs”. American Bar Association. Archived from the original on June 21, 2018. Retrieved August 30, 2019.

^ Sifferlin, Alexandra (October 3, 2015). “Over Half of E.U. Countries Are Opting Out of GMOs”. Time. Retrieved August 30, 2019.

^ Lynch, Diahanna; Vogel, David (April 5, 2001). “The Regulation of GMOs in Europe and the United States: A Case-Study of Contemporary European Regulatory Politics”. Council on Foreign Relations. Archived from the original on September 29, 2016. Retrieved August 30, 2019.

^ Pollack A (April 13, 2010). “Study Says Overuse Threatens Gains From Modified Crops”. The New York Times. Archived from the original on November 21, 2017. Retrieved February 24, 2017.

^ Brookes, Graham; Barfoot, Peter (May 8, 2017). “Farm income and production impacts of using GM crop technology 1996–2015”. GM Crops & Food. 8 (3): 156–193. doi:10.1080/21645698.2017.1317919. ISSN 2164-5698. PMC 5617554. PMID 28481684.

^ Tyczewska, Agata; Twardowski, Tomasz; Woźniak-Gientka, Ewa (January 2023). “Agricultural biotechnology for sustainable food security”. Trends in Biotechnology. 41 (3): 331–341. doi:10.1016/j.tibtech.2022.12.013. ISSN 0167-7799. PMC 9881846. PMID 36710131. S2CID 256304868.

^ Sairam, R. V.; Prakash, C. S. (July 2005). “OBPC Symposium: maize 2004 & beyond—Can agricultural biotechnology contribute to global food security?”. In Vitro Cellular & Developmental Biology – Plant. 41 (4): 424–430. doi:10.1079/ivp2005663. ISSN 1054-5476. S2CID 25855065.

^ Kumar, Pankaj; Kumar, Arun; Dhiman, Karuna; Srivastava, Dinesh Kumar (2021), “Recent Progress in Cereals Biofortification to Alleviate Malnutrition in India: An Overview”, Agricultural Biotechnology: Latest Research and Trends, Singapore: Springer Nature Singapore, pp. 253–280, doi:10.1007/978-981-16-2339-4_11, ISBN 978-981-16-2338-7, S2CID 245834290

^ Industrial Biotechnology and Biomass Utilisation Archived April 5, 2013, at the Wayback Machine

^ “Industrial biotechnology, A powerful, innovative technology to mitigate climate change”. Archived from the original on January 2, 2014. Retrieved January 1, 2014.

^ Clarke, Lionel; Kitney, Richard (February 28, 2020). “Developing synthetic biology for industrial biotechnology applications”. Biochemical Society Transactions. 48 (1): 113–122. doi:10.1042/BST20190349. ISSN 0300-5127. PMC 7054743. PMID 32077472.

^ McCarty, Nicholas S.; Ledesma-Amaro, Rodrigo (February 2019). “Synthetic Biology Tools to Engineer Microbial Communities for Biotechnology”. Trends in Biotechnology. 37 (2): 181–197. doi:10.1016/j.tibtech.2018.11.002. ISSN 0167-7799. PMC 6340809. PMID 30497870.

^ Zhou, Kang; Qiao, Kangjian; Edgar, Steven; Stephanopoulos, Gregory (April 2015). “Distributing a metabolic pathway among a microbial consortium enhances production of natural products”. Nature Biotechnology. 33 (4): 377–383. doi:10.1038/nbt.3095. ISSN 1087-0156. PMC 4867547. PMID 25558867.

^ Wu, Meng-Ying; Sung, Li-Yu; Li, Hung; Huang, Chun-Hung; Hu, Yu-Chen (December 15, 2017). “Combining CRISPR and CRISPRi Systems for Metabolic Engineering of E. coli and 1,4-BDO Biosynthesis”. ACS Synthetic Biology. 6 (12): 2350–2361. doi:10.1021/acssynbio.7b00251. ISSN 2161-5063. PMID 28854333.

^ Pakshirajan, Kannan; Rene, Eldon R.; Ramesh, Aiyagari (2014). “Biotechnology in environmental monitoring and pollution abatement”. BioMed Research International. 2014: 235472. doi:10.1155/2014/235472. ISSN 2314-6141. PMC 4017724. PMID 24864232.

^ Danso, Dominik; Chow, Jennifer; Streit, Wolfgang R. (October 1, 2019). “Plastics: Environmental and Biotechnological Perspectives on Microbial Degradation”. Applied and Environmental Microbiology. 85 (19). Bibcode:2019ApEnM..85E1095D. doi:10.1128/AEM.01095-19. ISSN 1098-5336. PMC 6752018. PMID 31324632.

^ Daniel A. Vallero, Environmental Biotechnology: A Biosystems Approach, Academic Press, Amsterdam, NV; ISBN 978-0-12-375089-1; 2010.

^ “Debate on robot trees looks to clear the air: What are other countries doing?”. The Echo. November 9, 2023. Retrieved January 17, 2024.

^ “The History and Future of GM Potatoes”. Potato Pro. March 10, 2010. Archived from the original on October 12, 2013. Retrieved January 1, 2014.

^ Wesseler J, Kalaitzandonakes N (2011). “Present and Future EU GMO policy”. In Oskam A, Meesters G, Silvis H (eds.). EU Policy for Agriculture, Food and Rural Areas (2nd ed.). Wageningen: Wageningen Academic Publishers. pp. 23–332.

^ Beckmann VC, Soregaroli J, Wesseler J (2011). “Coexistence of genetically modified (GM) and non-modified (non GM) crops: Are the two main property rights regimes equivalent with respect to the coexistence value?”. In Carter C, Moschini G, Sheldon I (eds.). Genetically modified food and global welfare. Frontiers of Economics and Globalization Series. Vol. 10. Bingley, UK: Emerald Group Publishing. pp. 201–224.

^ “Biotechnology Predoctoral Training Program”. National Institute of General Medical Sciences. December 18, 2013. Archived from the original on October 28, 2014. Retrieved October 28, 2014.